HR 1414 · 119th CongressIn Committeecongress.gov ↗
Road to The Floor
How it worksIntroduced
In Committee
On The Floor
Passed a Chamber
Passed Congress
To President
Became Law
What this bill does
AI plain-language summaryThis bill would increase a tax credit for companies that develop drugs for rare diseases. Currently, companies can get a tax credit equal to 25% of the money they spend on testing these drugs. This bill would raise that credit to 50%. The credit was previously 50% before 2018, when it was lowered to 25%.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.